Dataset DOI: 10.5061/dryad.8cz8w9h7x

Description of the data and file structure

The Excel file contains summarized phase-locking value (PLV) data derived from electrically evoked compound action potentials (eCAPs) recorded in three children with auditory neuropathy spectrum disorder (ANSD) and eight children with sensorineural hearing loss (SNHL). Some or all of these data have been previously reported in the following three publications.

1.    He S, Bruce IC, Gao Z, Aiello RA, Mueller CR. Evaluating the N1-P2 Interpeak Latency of the eCAP and Its Intertrial Variability as Potential Indicators of Neural Synchrony in the Auditory Nerve of Cochlear Implant Users. J Assoc Res Otolaryngol. 2026 May 11. doi: 10.1007/s10162-026-01051-1. Epub ahead of print. PMID: 42115509.

2.    He S, Gao Z, Oleson JJ, Bruce IC. The Interphase Gap Effect in Cochlear Implant Users: Biological Basis, Parameter Selection, Analytical Methods, and Quantitative Scales. J Assoc Res Otolaryngol. 2026 Mar 16. doi: 10.1007/s10162-026-01041-3. Epub ahead of print. PMID: 41840299.

3.    He S, Gao Z, Oleson JJ. Electrically Evoked Compound Action Potentials in Adult and Pediatric Cochlear Implant Users: II. Assessing Cochlear Nerve Health Status with the Interphase Gap Effect and the Phase Locking Value. Hear Res. 2026 June 1. doi.org/10.1016/j.heares.2026.109693.

Please note that the cells in line 11, columns C and D were marked as “n/a” because the averaged electrically evoked compound action potential (eCAP) across all single sweeps had an amplitude lower than the device’s noise floor. As a result, the eCAP response was considered unreliable and not suitable for further analysis.

Files and variables

File: Summerized_phase_locking_data.xlsx

Variables

• SubjectCode: subject number used in the associated publications. Participants with auditory neuropathy spectrum disorder (ANSD) are identified by the suffix “_ANSD” in the subject code. Other participants have typical, non-ANSD sensorineural hearing loss. 
• electrode: cochlear implant electrode number tested in each ear or participant. 
• Phase_lockingValue: the phase locking value derived from electrophysiological measures of the electrically evoked compound action potential (eCAP) measured at each tested cochlear implant electrode location. 
• ECAPAmplitude_uV: amplitude of the averaged eCAP response across all eCAP sweeps measured in microvolt. 

Code/software

None. 

Human subjects data

We obtained informed consent from all participants to publish de-identified data in the public domain. Before data sharing, all datasets were thoroughly de-identified in accordance with institutional and ethical guidelines. Direct personal identifiers, including names, dates of birth, medical record numbers, addresses, telephone numbers, email addresses, and any other protected health information, were removed. Indirect identifiers that could reasonably be used to identify an individual, such as exact dates of clinical visits or testing, were also removed or generalized as appropriate. As a result, the published dataset contains only research variables that cannot reasonably be linked to individual participants, thereby protecting participant privacy while allowing the data to be used for research and verification purposes.